[1]高自然,赵郭盛,彭动斌,等.印记基因TSSC3对骨肉瘤血管生成的影响[J].第三军医大学学报,2018,40(10):855-861.
 GAO Ziran,ZHAO Guosheng,PENG Dongbin,et al.Effect of overexpression of imprinted gene TSSC3 on angiogenesis in human osteosarcoma[J].J Third Mil Med Univ,2018,40(10):855-861.
点击复制

印记基因TSSC3对骨肉瘤血管生成的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第10期
页码:
855-861
栏目:
基础医学
出版日期:
2018-05-30

文章信息/Info

Title:
Effect of overexpression of imprinted gene TSSC3 on angiogenesis in human osteosarcoma
作者:
高自然赵郭盛彭动斌吕杨帆郭乔楠
陆军军医大学(第三军医大学)第二附属医院病理科;重庆医科大学第一附属医院骨科
Author(s):
GAO Ziran1 ZHAO Guosheng PENG Dongbin LYU Yangfan GUO Qiaonan

Department of Pathology, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037; Department of Orthopedics, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

关键词:
TSSC3骨肉瘤血管生成血管内皮生长因子A
Keywords:
TSSC3 osteosarcoma angiogenesis vascular endothelial growth factor A
分类号:
R394.3;R364.3;R738.1
文献标志码:
A
摘要:

目的    通过体内外实验观察印记基因TSSC3对骨肉瘤血管生成的影响。方法    利用慢病毒建立稳定过表达TSSC3的骨肉瘤MTH细胞株,收集骨肉瘤细胞上清制备条件培养基(conditional medium,CM);通过划痕实验、Transwell实验及小管形成实验观察CM对人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVEC)的迁移和小管形成能力的影响;RT-PCR、Western blot及酶联免疫吸附试验(ELISA)检测骨肉瘤细胞中血管内皮生长因子A(vascular endothelial growth factor A,VEGFA)mRNA及蛋白水平变化;建立裸鼠移植瘤模型,免疫组化检测肿瘤组织中VEGFA蛋白及微血管密度(microvessel density,MVD)的表达情况。结果    过表达TSSC3(overTSSC3)组CM抑制内皮细胞迁移和小管形成,与对照组比较差异有统计学意义(P<0.01);RT-PCR、Western blot及ELISA检测结果显示,overTSSC3组细胞较对照组VEGFA mRNA和蛋白表达水平降低,差异有统计学意义(P<0.01);裸鼠移植瘤免疫组化检测结果显示,overTSSC3组肿瘤中VEGFA蛋白表达量及MVD明显低于对照组。结论    印记基因TSSC3可能通过下调VEGFA的表达进而抑制骨肉瘤血管生成。

Abstract:

Objective    To observe the effect of imprinted gene TSSC3 overexpression on angiogenesis in human osteosarcoma. Methods    TSSC3 gene was transduced in human osteosarcoma MTH cells via lentiviral vector, and the culture supernatant was collected from the cells with and without TSSC3 gene transduction to prepare the conditional medium (CM) of osteosarcoma cells. Wound healing assay, Transwell migration assay and tube formation assay were used to assess the effect of CM on the migration and tube formation ability of human umbilical vein endothelial cells (HUVEC) in vitro. Real-time fluorescence quantitative PCR (RT-PCR) and Western blotting were used to detect the expression of vascular endothelial growth factor A (VEGFA) mRNA and protein in MTH cells, and VEGFA concentration in the CM was detected using enzymelinked immunosorbent assay (ELISA). The expression of VEGFA and CD34 in MTH cell xenograft in a nude mice model was determined using immunohistochemistry. ResultsThe CM from MTH cells overexpressing TSSC3 significantly suppressed the migration and tube formation of HUVECs. The results of RT-PCR, Western blotting and ELISA showed that TSSC3 overexpression caused significantly lowered expression of VEGFA at both the mRNA and protein levels in MTH cells (P<0.01). In the tumor-bearing nude mice, VEGFA expression and microvessel density was significantly lowered in TSSC3-overexpressing MTH cell xenograft as compared with those in the control group. Conclusion    TSSC3 suppresses angiogenesis in osteosarcoma possibly by down-regulating the expression of VEGFA.

参考文献/References:

[1]ROGOZHIN D V, BULYCHEVA I V, KONOVALOV D M, et al. Classical osteosarcoma in children and adolescent[J]. Arkh Patol, 2015,77(5): 68-74. DOI:  10.17116/patol201577568-74.
[2]XIE L, JI T, GUO W. Antiangiogenesis target therapy for advanced osteosarcoma [J]. Oncol Rep, 2017,38(2): 625-636. DOI: 10.3892/or.2017.5735.
[3]JAIN R K. Antiangiogenesis strategies revisited:  from starving tumors to alleviating hypoxia[J]. Cancer Cell, 2014,26(5): 605-622. DOI: 10.1016/j.ccell.2014.10.006.
[4]DAI H, HUANG Y, LI Y, et al. TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma[J]. Carcinogenesis, 2012,33(1): 30-40. DOI: 10.1093/carcin/bgr232.
[5]HUANG Y, DAI H, GUO Q N. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells[J]. Apoptosis, 2012,17(8): 749-761. DOI: 10.1007/s10495-012-0734-1.
[6]YAN G N, TANG X F, ZHANG X C, et al. TSSC3 represses selfrenewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway[J]. Oncotarget, 2017, 8(49):  85628-85641. DOI: 10.18632/oncotarget.20429.
[7]LV Y F, DAI H, YAN G N, et al. Downregulation of tumor suppressing STF cDNA 3 promotes epithelialmesenchymal transition and tumor metastasis of osteosarcoma by the Wnt/GSK-3β/β-catenin/Snail signaling pathway[J]. Cancer Lett, 2016,373(2): 164-173. DOI: 10.1016/j.canlet.2016.01.046.
[8]FOLKMAN J. Tumor angiogenesis:  therapeutic implications[J]. N Engl J Med, 1971, 285(21):  1182-1186. DOI: 10.1056/NEJM197111182852108.
[9]张静, 张文超, 钱子君, 等. 血管正常化提高肿瘤治疗疗效[J]. 中国癌症杂志, 2016, 26(2):  188-192. DOI: 10.3969/j.issn.10073969.2016.02.012.
ZHANG J, ZHANG W C, QIAN Z J, et al. Tumor vascular normalization improves cancer treatment efficacy[J]. China Oncology, 2016,26(2): 188-192. DOI: 10.3969/j.issn.1007-3969.2016.02.012.
[10]RIBARSKA T, GOERING W, DROOP J, et al. Deregulation of an imprinted gene network in prostate cancer[J]. Epigenetics, 2014, 9(5): 704-717. DOI: 10.4161/epi.28006.
[11]刘岩, 王芳. 印记基因调控肿瘤的研究进展[J]. 医学研究生学报, 2016,29(1): 87-91.DOI:  10.16571/j.cnki.1008-8199.2016.01.018.
LIU Y, WANG F. Imprinted gene network regulation in tumor: Advances in researches[J]. J Med Postgraduates, 2016, 29(1): 87-91. DOI: 10.16571/j.cnki.1008-8199.2016.01.018.
[12]APOSTOLIDOU S, ABU-AMERO S, O’DONOGHUE K, et al. Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight[J]. J Mol Med, 2007, 85(4): 379-387. DOI: 10.1007/s00109-006-0131-8.
[13]M LLER S, VAN DEN BOOM D, ZIRKEL D, et al. Retention of imprinting of the human apoptosisrelated gene TSSC3 in human brain  tumors[J]. Hum Mol Genet, 2000, 9(5): 757-763. DOI:  10.1093/hmg/9.5.757.
[14]WANG X, HE H, ZHANG K, et al. The expression of TSSC3 and its prognostic value in patients with osteosarcoma[J]. Biomed Pharmacother, 2016,79: 23-26. DOI: 10.1016/j.biopha.2015.10. 013.
[15]HSU Y L, HUNG J Y, LEE Y L, et al. Identification of novel gene expression signature in lung adenocarcinoma by using nextgeneration sequencing data and bioinformatics analysis[J]. Oncotarget, 2017,8(62): 104831-104854. DOI: 10.18632/oncotarget.21022.
[16]COMUNANZA V, BUSSOLINO F. Therapy for cancer:  strategy of combining antiangiogenic and target therapies[J]. Front Cell Dev Biol, 2017, 5: 101. DOI: 10.3389/fcell.2017.00101.
[17]TABONE M D, BRUGI RES L, PIPERNONEUMANN S, et al. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma:  a prospective study[J]. BMC Cancer, 2017,17(1): 419. DOI:  10.1186/s12885-017-3409-z.
[18]RASTOGI S, KUMAR R, SANKINEANI S R, et al. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma:  a prospective study[J]. Int Orthop, 2012,36(11): 2315-2321. DOI: 10.1007/s00264-012-1663-x.
[19]ZHAO J, ZHANG Z R, ZHAO N, et al. VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway[J]. Cell Biochem Biophys, 2015,73(2): 519-525.DOI:  10.1007/s12013-015-0692-7.

相似文献/References:

[1]蒋平,关伟,戴楠,等.DNA损伤修复基因以及TS、β-tubulinⅢ在骨肉瘤中的表达及其与临床病理的关系[J].第三军医大学学报,2013,35(01):61.
 Jiang Ping,Guan Wei,Dai Nan,et al.Expression of DNA damage repair genes, thymidylate synthase and β-tubulin Ⅲ in human osteosarcoma tissues and its relationship with clinical pathology of osteosarcoma[J].J Third Mil Med Univ,2013,35(10):61.
[2]温磊,孟刚,李懿,等.人骨肉瘤抗失巢凋亡细胞的生物学特性研究[J].第三军医大学学报,2008,30(10):942.
 WEN Lei,MENG Gang,LI Yi,et al.Biological characteristics of anoikis-resistant cells from human osteosarcoma cell line hFOB1.19[J].J Third Mil Med Univ,2008,30(10):942.
[3]李懿,孟刚,郭乔楠.P53和P63蛋白在人骨肉瘤组织及恶性转化细胞株中的表达变化及意义[J].第三军医大学学报,2006,28(08):763.
[4]仲召阳,王东,李增鹏,等.骨肉瘤中APE1的表达及其与血管生成的关系[J].第三军医大学学报,2005,27(10):1045.
[5]卫佳,李星星,陈英华,等.β-catenin降低外源性hS100A6对骨肉瘤细胞的抑制作用[J].第三军医大学学报,2010,32(16):1703.
 Wei Jia,Li Xingxing,Chen Yinghua,et al.β-catenin decreases hS100A6-induced inhibition in osteosarcoma cell lines MG63 and U2OS[J].J Third Mil Med Univ,2010,32(10):1703.
[6]王东,仲召阳,李增鹏,等.骨肉瘤中ephrinB2/EphB4的表达及其与血管生成的关系[J].第三军医大学学报,2004,26(22):0.[doi:10.16016/j.1000-5404.2004.22.024 ]
 WANG Dong,ZHONG Zhao-yang,LI Zeng-peng,et al.[J].J Third Mil Med Univ,2004,26(10):0.[doi:10.16016/j.1000-5404.2004.22.024 ]
[7]何畔,梁珊.RNAi抑制XIAP基因诱导MG63细胞凋亡、化疗增敏及其分子机制[J].第三军医大学学报,2010,32(12):1312.
 He Pan,Liang Shan.RNAi silencing of XIAP gene induces apoptosis and susceptibility to chemotherapy of osteosarcoma cell line MG63[J].J Third Mil Med Univ,2010,32(10):1312.
[8]曾静,温磊,黄玉胜,等.神经营养因子酪氨酸激酶受体B对人永生化成骨细胞hFOB1.19恶性转化细胞体外侵袭力的影响[J].第三军医大学学报,2010,32(09):938.
 Zeng Jing,Wen Lei,Huang Yusheng,et al.Effect of neurotrophic tyrosine kinase receptor B on in vitro invasiveness of malignant transformed hFOB1.19 cells[J].J Third Mil Med Univ,2010,32(10):938.
[9]洪思琦,毕杨,郭振华,等.携带siANGPTL4重组腺病毒的构建及其对MG63增殖的抑制作用[J].第三军医大学学报,2011,33(01):28.
 Hong Siqi,Bi Yang,Guo Zhenhua,et al.Construction of recombinant adenovirus with siANGPTL4 gene and its inhibitive effect on MG63 cell proliferation[J].J Third Mil Med Univ,2011,33(10):28.
[10]周斌,李宏维,史继德,等.PNKP沉默对骨肉瘤放疗的增敏作用[J].第三军医大学学报,2016,38(04):390.
 Zhou Bin,Li Hongwei,Shi Jide,et al.PNKP silencing increases radiosensitivity of osteosarcoma cells in vitro[J].J Third Mil Med Univ,2016,38(10):390.

更新日期/Last Update: 2018-05-29